Form 4: Ekso Bionics CFO Jerome Wong Reports Acquisition of Shares Through 401(k) Program

Jerome Wong, CFO of Ekso Bionics Holdings, Inc., reports acquiring 7,474 shares of common stock through the company's 401(k) contribution matching program on March 22, 2024.

Summary

• On March 22, 2024, Jerome Wong, the Chief Financial Officer of Ekso Bionics Holdings, Inc., acquired 7,474 shares of common stock.
• The acquisition was made through the Issuer's 401(k) contribution matching program.
• Following the transaction, Wong directly owns 266,953 shares of common stock and indirectly owns 18,887 shares through a 401(k).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to employee benefits and doesn't provide strong positive or negative signals about the company's performance.

Positives

• The acquisition of shares by a company officer can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect a major strategic shift for Ekso Bionics within the broader robotics and medical device industry.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a key executive.

Key Dates

Keywords

Ekso Bionics, Jerome Wong, CFO, Form 4, Beneficial Ownership, 401(k), Common Stock, Acquisition